High levels of SAA1 in the blood or tumor tissue have been associated with poor prognosis in patients with lung cancer, gastric cancer, endometrial cancer, prostate cancer, melanoma and esophageal cancer and have been suggested as potential biomarkers for several types of cancer [40]. The gene discussed is SAA1; the disease is lung carcinoma.